Cargando…

Mingmu Xiaoyao granules regulate the PI3K/Akt/mTOR signaling pathway to reduce anxiety and depression and reverse retinal abnormalities in rats

Objective: To investigate the effects of Mingmu Xiaoyao granules (MMXY) on the morphology and function of the retina and the mechanism of PI3K/Akt/mTOR pathway-related proteins in rats with anxiety and depression induced by chronic unpredictable mild stress (CUMS). Methods: Fifty-two male Sprague Da...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Qiuyan, Zhou, Jian, Yang, Ziyi, Xue, Yuxin, Xie, Xinran, Li, Tiejun, Yang, Yingxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579374/
https://www.ncbi.nlm.nih.gov/pubmed/36278192
http://dx.doi.org/10.3389/fphar.2022.1003614
_version_ 1784812166927351808
author Ma, Qiuyan
Zhou, Jian
Yang, Ziyi
Xue, Yuxin
Xie, Xinran
Li, Tiejun
Yang, Yingxin
author_facet Ma, Qiuyan
Zhou, Jian
Yang, Ziyi
Xue, Yuxin
Xie, Xinran
Li, Tiejun
Yang, Yingxin
author_sort Ma, Qiuyan
collection PubMed
description Objective: To investigate the effects of Mingmu Xiaoyao granules (MMXY) on the morphology and function of the retina and the mechanism of PI3K/Akt/mTOR pathway-related proteins in rats with anxiety and depression induced by chronic unpredictable mild stress (CUMS). Methods: Fifty-two male Sprague Dawley rats were randomly allocated to either a control (n = 14) or a simulated CUMS group (n = 38). The CUMS model was established successfully at 4 weeks. Six rats in each group were randomly selected to be sacrificed and their retinas isolated for histological examination. At 5 weeks, rats in the CUMS group were randomly allocated to the following groups: Model (CUMS + pure water), MMXY-H (CUMS + MMXY 7.2 g/kg/d), MMXY-L (CUMS + MMXY 3.6 g/kg/d), and CBZ (CUMS + Carbamazepine 20 mg/kg/d), with eight rats in each group. All rats were given the relevant intervention once a day. At 12 weeks, sucrose preference and open field tests were performed to evaluate the anxiety and depression status of rats. In live rats, optical coherence tomography angiography was used to measure retinal thickness and blood flow, while electroretinograms (ERGs) and visual evoked potentials (VEPs) were used to evaluate retinal function. The next day, the specimens were sacrificed for serological, histological, immunofluorescence, Western blot and transmission electron microscopy examinations to explore the mechanism of MMXY in CUMS rats. Results: MMXY improved the anxiety and depression-like behavior of rats. Results of optical coherence tomography angiography showed that MMXY improved retinal inner thickness and blood flow in CUMS rats. MMXY improved the amplitude of a- and b-waves in the scotopic and photopic ERG, as well as N2 and P2 peak time and amplitude in the flash-VEP in CUMS rats. Retinal histological staining and transmission electron microscopy showed that MMXY reversed retinal morphology and ultrastructure in CUMS rats. MMXY reduced the expression of Beclin1 and LC3I/II proteins, regulated the PI3K/Akt/mTOR pathway, inhibited autophagy, and had a protective effect on the retina in CUMS rats. Conclusion: MMXY may effectively improve retinal morphology and function as well as anxiety and depression-like behaviors in CUMS rats by regulating the PI3K/Akt/mTOR signaling pathway.
format Online
Article
Text
id pubmed-9579374
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95793742022-10-20 Mingmu Xiaoyao granules regulate the PI3K/Akt/mTOR signaling pathway to reduce anxiety and depression and reverse retinal abnormalities in rats Ma, Qiuyan Zhou, Jian Yang, Ziyi Xue, Yuxin Xie, Xinran Li, Tiejun Yang, Yingxin Front Pharmacol Pharmacology Objective: To investigate the effects of Mingmu Xiaoyao granules (MMXY) on the morphology and function of the retina and the mechanism of PI3K/Akt/mTOR pathway-related proteins in rats with anxiety and depression induced by chronic unpredictable mild stress (CUMS). Methods: Fifty-two male Sprague Dawley rats were randomly allocated to either a control (n = 14) or a simulated CUMS group (n = 38). The CUMS model was established successfully at 4 weeks. Six rats in each group were randomly selected to be sacrificed and their retinas isolated for histological examination. At 5 weeks, rats in the CUMS group were randomly allocated to the following groups: Model (CUMS + pure water), MMXY-H (CUMS + MMXY 7.2 g/kg/d), MMXY-L (CUMS + MMXY 3.6 g/kg/d), and CBZ (CUMS + Carbamazepine 20 mg/kg/d), with eight rats in each group. All rats were given the relevant intervention once a day. At 12 weeks, sucrose preference and open field tests were performed to evaluate the anxiety and depression status of rats. In live rats, optical coherence tomography angiography was used to measure retinal thickness and blood flow, while electroretinograms (ERGs) and visual evoked potentials (VEPs) were used to evaluate retinal function. The next day, the specimens were sacrificed for serological, histological, immunofluorescence, Western blot and transmission electron microscopy examinations to explore the mechanism of MMXY in CUMS rats. Results: MMXY improved the anxiety and depression-like behavior of rats. Results of optical coherence tomography angiography showed that MMXY improved retinal inner thickness and blood flow in CUMS rats. MMXY improved the amplitude of a- and b-waves in the scotopic and photopic ERG, as well as N2 and P2 peak time and amplitude in the flash-VEP in CUMS rats. Retinal histological staining and transmission electron microscopy showed that MMXY reversed retinal morphology and ultrastructure in CUMS rats. MMXY reduced the expression of Beclin1 and LC3I/II proteins, regulated the PI3K/Akt/mTOR pathway, inhibited autophagy, and had a protective effect on the retina in CUMS rats. Conclusion: MMXY may effectively improve retinal morphology and function as well as anxiety and depression-like behaviors in CUMS rats by regulating the PI3K/Akt/mTOR signaling pathway. Frontiers Media S.A. 2022-10-05 /pmc/articles/PMC9579374/ /pubmed/36278192 http://dx.doi.org/10.3389/fphar.2022.1003614 Text en Copyright © 2022 Ma, Zhou, Yang, Xue, Xie, Li and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ma, Qiuyan
Zhou, Jian
Yang, Ziyi
Xue, Yuxin
Xie, Xinran
Li, Tiejun
Yang, Yingxin
Mingmu Xiaoyao granules regulate the PI3K/Akt/mTOR signaling pathway to reduce anxiety and depression and reverse retinal abnormalities in rats
title Mingmu Xiaoyao granules regulate the PI3K/Akt/mTOR signaling pathway to reduce anxiety and depression and reverse retinal abnormalities in rats
title_full Mingmu Xiaoyao granules regulate the PI3K/Akt/mTOR signaling pathway to reduce anxiety and depression and reverse retinal abnormalities in rats
title_fullStr Mingmu Xiaoyao granules regulate the PI3K/Akt/mTOR signaling pathway to reduce anxiety and depression and reverse retinal abnormalities in rats
title_full_unstemmed Mingmu Xiaoyao granules regulate the PI3K/Akt/mTOR signaling pathway to reduce anxiety and depression and reverse retinal abnormalities in rats
title_short Mingmu Xiaoyao granules regulate the PI3K/Akt/mTOR signaling pathway to reduce anxiety and depression and reverse retinal abnormalities in rats
title_sort mingmu xiaoyao granules regulate the pi3k/akt/mtor signaling pathway to reduce anxiety and depression and reverse retinal abnormalities in rats
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579374/
https://www.ncbi.nlm.nih.gov/pubmed/36278192
http://dx.doi.org/10.3389/fphar.2022.1003614
work_keys_str_mv AT maqiuyan mingmuxiaoyaogranulesregulatethepi3kaktmtorsignalingpathwaytoreduceanxietyanddepressionandreverseretinalabnormalitiesinrats
AT zhoujian mingmuxiaoyaogranulesregulatethepi3kaktmtorsignalingpathwaytoreduceanxietyanddepressionandreverseretinalabnormalitiesinrats
AT yangziyi mingmuxiaoyaogranulesregulatethepi3kaktmtorsignalingpathwaytoreduceanxietyanddepressionandreverseretinalabnormalitiesinrats
AT xueyuxin mingmuxiaoyaogranulesregulatethepi3kaktmtorsignalingpathwaytoreduceanxietyanddepressionandreverseretinalabnormalitiesinrats
AT xiexinran mingmuxiaoyaogranulesregulatethepi3kaktmtorsignalingpathwaytoreduceanxietyanddepressionandreverseretinalabnormalitiesinrats
AT litiejun mingmuxiaoyaogranulesregulatethepi3kaktmtorsignalingpathwaytoreduceanxietyanddepressionandreverseretinalabnormalitiesinrats
AT yangyingxin mingmuxiaoyaogranulesregulatethepi3kaktmtorsignalingpathwaytoreduceanxietyanddepressionandreverseretinalabnormalitiesinrats